Halozyme Therapeutics saw the highest growth of 899% in patent filings in January and 499% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 899% and grants by 249%. GlobalData’s DataBook provides a comprehensive analysis of Halozyme Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Halozyme Therapeutics has been focused on protecting inventions in United States(US) with 12 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 83% filings and 18% grants. The United States(US), European Patent Office(EPO), Finland(FI), and Japan(JP) patent Office are among the top ten patent offices where Halozyme Therapeutics is filings its patents. Among the top granted patent authorities, Halozyme Therapeutics has 27% of its grants in European Patent Office(EPO), 18% in United States(US) and 18% in Finland(FI).

F. Hoffmann-La Roche could be the strongest competitor for Halozyme Therapeutics

Patents related to rare diseases and climate change lead Halozyme Therapeutics's portfolio

Halozyme Therapeutics has the highest number of patents in rare diseases followed by, climate change and addiction. For rare diseases, nearly 46% of patents were filed and no patents were granted in Q1 2024.

Drug delivery devices related patents lead Halozyme Therapeutics portfolio followed by diphtheria, and japanese encephalitis

Halozyme Therapeutics has highest number of patents in drug delivery devices followed by diphtheria, japanese encephalitis, yellow fever, and hepatitis b. For drug delivery devices, nearly 2% of patents were filed and 50% of patents were granted in Q1 2024.

For comprehensive analysis of Halozyme Therapeutics's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.